1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Kidney Disease Market – By Product

1.3.2        Kidney Disease Market – By End User

1.3.3        South & Central America Kidney Disease – By Country

2.           South & Central America Kidney Disease – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South & Central AmericaKidney Disease – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Kidney Disease Market- South & Central America PEST Analysis

4.3         Expert Opinion

5.           South & Central AmericaKidney Disease - Key Market Dynamics

5.1         Market Drivers

5.1.1        Higher prevalence of Kidney Diseases in South & Central America

5.1.2        Rising Incidence Rates of Hypertension

5.2         Market Restraints

5.2.1        Inadequate Workforce to Fight the Burden of Kidney Diseases

5.3         Market Opportunities

5.3.1        Increased Contribution by the Governments of the Countries

5.4         Future Trends

5.4.1        Increased Number of Product Launches and Company Collaborations

5.5         Impact Analysis

6.           Kidney Disease Market – South & Central America Analysis

6.1         South & Central AmericaKidney Disease Revenue Forecasts and Analysis

7.           South & Central AmericaKidney Disease Analysis and Forecasts To 2027 – ByProduct

7.1         Overview

7.2         Kidney Disease Market Revenue Share, by Product (2019 and 2027)

7.3         Diagnosis

7.3.1        Overview

7.3.2        Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.3        Blood Tests

7.3.3.1          Overview

7.3.3.2          Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027(US$ Million)

7.3.4        Urine Tests

7.3.4.1          Overview

7.3.4.2          Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.5        Imaging Tests

7.3.5.1          Overview

7.3.5.2          Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.6        Others

7.3.6.1          Overview

7.3.6.2          Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Treatment

7.4.1        Overview

7.4.2        Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3        Drug Class

7.4.3.1          Overview

7.4.3.2          Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.1          ACE Inhibitors

7.4.3.2.1.1       Overview

7.4.3.2.1.2       ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.2          Angiotensin-II Receptor Blockers

7.4.3.2.2.1       Overview

7.4.3.2.2.2       Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.3          Diuretics

7.4.3.2.3.1       Overview

7.4.3.2.3.2       Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.4          Others

7.4.3.2.4.1       Overview

7.4.3.2.4.2       Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.4        Dialysis

7.4.4.1          Overview

7.4.4.2          Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.5        Others

7.4.5.1          Overview

7.4.5.2          Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.           South & Central AmericaKidney Disease Analysis – By End-User

8.1         Overview

8.2         Kidney Disease Market Revenue Share, by End User (2019 and 2027)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Diagnostic Laboratories

8.4.1        Overview

8.4.2        Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

9.           Kidney Disease Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         South and Central America: Kidney Disease Market

9.1.1        Overview

9.1.2        South and Central America: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        South and Central America: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          South and Central America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          South and Central America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.3.2.1          South and Central America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.4        South and Central America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.5        South and Central America: Kidney Disease Market, by Country, 2019 & 2027 (%)

9.1.6        Brazil: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          Brazil: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          Brazil: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.1          Brazil: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2          Brazil: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2.1       Brazil: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          Brazil: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.7        Argentina: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Argentina: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Argentina: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.1          Argentina: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2          Argentina: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2.1       Argentina: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.7.3          Argentina: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.        Impact Of COVID-19 Pandemic on South & Central AmericaKidney Disease

10.1      South & Central America: Impact Assessment of COVID-19 Pandemic

11.        COMPANY PROFILES

11.1      Abbott

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      F. Hoffmann-La Roche Ltd.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Teva Pharmaceutical Industries Ltd

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      GlaxoSmithKline plc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

Source: Press Release, Newsletters, and Company Annual Report

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of terms

Table 1.             South and Central America: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             South and Central America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 3.             South and Central America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 4.             South and Central America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 5.             South and Central America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             Brazil: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 7.             Brazil: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 8.             Brazil: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 9.             Brazil: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10.          Brazil: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Argentina: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 12.          Argentina: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 13.          Argentina: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 14.          Argentina: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 15.          Argentina: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Glossary of Terms,Kidney disease

Figure 1.           Kidney Disease Segmentation

Figure 2.           South & Central AmericaKidney Disease Overview

Figure 3.           Diagnosis Segment Held Largest Share of Product inKidney Disease Market

Figure 4.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Kidney Disease Market - South & Central America PEST Analysis

Figure 6.           Kidney Disease Market Impact Analysis of Driver and Restraints

Figure 7.           South & Central AmericaKidney Disease – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.           Kidney Disease Market Revenue Share, by Product (2019 and 2027)

Figure 9.           Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Kidney Disease Market Revenue Share, by End User (2019 and 2027)

Figure 23.        Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        South and Central America: Kidney Disease Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.        South and Central America Kidney Disease Market Revenue and Forecast to 2027 (USD Million)

Figure 28.        South and Central America: Kidney Disease Market, by Country, 2019 & 2027 (%)

Figure 29.        Brazil: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Argentina: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Impact of COVID-19 Pandemic in South & Central Americaon Country Markets